A purified Bacillus thuringiensis crystal protein with therapeutic activity against the hookworm parasite Ancylostoma ceylanicum.
about
Developing novel anthelmintics from plant cysteine proteinases.Drug Repositioning and Pharmacophore Identification in the Discovery of Hookworm MIF InhibitorsStructure and Glycolipid Binding Properties of the Nematicidal Protein Cry5BBacillus thuringiensis Cry5B protein is highly efficacious as a single-dose therapy against an intestinal roundworm infection in miceCure of hookworm infection with a cysteine protease inhibitorMechanistic and single-dose in vivo therapeutic studies of Cry5B anthelmintic action against hookwormsBacillus thuringiensis-derived Cry5B has potent anthelmintic activity against Ascaris suumBacillus thuringiensis Is an Environmental Pathogen and Host-Specificity Has Developed as an Adaptation to Human-Generated Ecological NichesAnthelmintic Effect of Bacillus thuringiensis Strains against the Gill Fish Trematode Centrocestus formosanusActivation of the unfolded protein response is required for defenses against bacterial pore-forming toxin in vivo.WWP-1 is a novel modulator of the DAF-2 insulin-like signaling network involved in pore-forming toxin cellular defenses in Caenorhabditis elegans.Discovery of a highly synergistic anthelmintic combination that shows mutual hypersusceptibilityWhole-genome phylogenies of the family Bacillaceae and expansion of the sigma factor gene family in the Bacillus cereus species-group.The pore-forming protein Cry5B elicits the pathogenicity of Bacillus sp. against Caenorhabditis elegans.Divergence of the SigB regulon and pathogenesis of the Bacillus cereus sensu lato group.RAB-5- and RAB-11-dependent vesicle-trafficking pathways are required for plasma membrane repair after attack by bacterial pore-forming toxin.Epidemiology of hookworm infection in Kintampo North Municipality, Ghana: patterns of malaria coinfection, anemia, and albendazole treatment failure.Molecular cloning and characterization of a C-type lectin from Ancylostoma ceylanicum: evidence for a role in hookworm reproductive physiology.Bacillus thuringiensis Crystal Protein Cry6Aa Triggers Caenorhabditis elegans Necrosis Pathway Mediated by Aspartic Protease (ASP-1).Oxadiazole 2-oxides are toxic to the human hookworm, Ancylostoma ceylanicum, however glutathione reductase is not the primary target.A furoxan-amodiaquine hybrid as a potential therapeutic for three parasitic diseases().Role for nitric oxide in hookworm-associated immune suppression.Bacillus subtilis strain engineered for treatment of soil-transmitted helminth diseasesOdanacatib, a Cathepsin K Cysteine Protease Inhibitor, Kills Hookworm In VivoCharacterisation of a fatty acid and retinol binding protein orthologue from the hookworm Ancylostoma ceylanicum.In vitro screening of compounds against laboratory and field isolates of human hookworm reveals quantitative differences in anthelmintic susceptibility.Bacterial pore-forming proteins as anthelmintics.Intracellular and Extracellular Expression of Bacillus thuringiensis Crystal Protein Cry5B in Lactococcus lactis for Use as an Anthelminthic.Entomotoxic and nematotoxic lectins and protease inhibitors from fungal fruiting bodies.Twenty-first century progress toward the global control of human hookworm infection.A Novel Fucose-binding Lectin from Photorhabdus luminescens (PLL) with an Unusual Heptabladed β-Propeller Tetrameric Structure.The Global State of Helminth Control and Elimination in Children.Larvicidal activity of Bacillus thuringiensis var. israelensis Cry11Aa toxin against Haemonchus contortus.Protection and Delivery of Anthelmintic Protein Cry5B to Nematodes Using Mesoporous Silicon Particles.Responses of 9 lepidopteran species to Bacillus thuringiensis: How useful is phylogenetic relatedness for selecting surrogate species for nontarget arthropod risk assessment?Resistance to Bacillus thuringiensis toxin in Caenorhabditis elegans from loss of fucose.Mucosal antibody responses in experimental hookworm infection.In vivo and in vitro studies of Cry5B and nicotinic acetylcholine receptor agonist anthelmintics reveal a powerful and unique combination therapy against intestinal nematode parasitesBacillus thuringiensis Cry5B protein as a new pan-hookworm cure.In vitro ovicidal and cestocidal effects of toxins from Bacillus thuringiensis on the canine and human parasite Dipylidium caninum
P2860
Q24658119-D29C21B9-4A96-40B0-82D7-212DF1E88144Q27674416-6223F0EF-92F6-4426-816D-816AD496FF9EQ27675127-157662D2-0408-4A81-A75A-2E8BB6C342C7Q28473074-D4EC1280-E55B-41F2-841B-904F83642D68Q28480978-98393366-A9A6-4D0B-8270-84117A92557BQ28484987-9BDA8225-8786-4837-B6A1-FD9C80AE3AB1Q28534011-6F884416-B5F5-4F4E-AF67-F6758E055BACQ28606950-D36D47BA-AD0F-4120-8155-AC0BAB27F9A8Q28829800-A5207C8E-C5C5-493C-A275-CFB51DF58FACQ33375026-0616911C-76B1-48AA-B18E-A383D96D97D2Q33538090-4C297990-F015-41A5-8316-B455DDAF6FB0Q33778375-9BF5AA38-638D-42B3-AD95-8B2920E2A52CQ34001863-D8511CE5-47F4-4D02-84BA-12A81B6A3538Q34117229-E8CD2994-0EC9-4F81-B385-9C13F539B1CBQ34453985-9B9ADDD1-5FE4-4A99-AA96-E111D869BE7CQ34673172-88EA7CED-D9EE-4FB8-A0B7-96615C418871Q34875733-161E7D0B-BB29-447F-95FB-F71A31DE8395Q35697108-F8C98D4B-E51E-48D4-A49A-B7AC3D5DE249Q35900236-077AE783-A5CE-4140-BEF6-3A9FEA3BCFE1Q36115719-82C59C96-3397-4F18-8A7E-127E8E28064FQ36432948-D833FBF8-F0AF-46BA-B477-CB56139CDFD7Q36710725-71A688CE-202C-4B26-91FB-96DE3AEB1343Q37123637-C81AC1D8-ACEC-45A5-A894-7736132B33F8Q37290813-30F1B59B-E123-47AA-84C7-9F6C37E88857Q37384521-9850CACF-C3C8-48AD-BB53-90D78FD021EAQ37456181-4E336868-F531-4746-90C3-36DBB7E1EE26Q37469105-8CB33F5B-4EC9-4B6E-94EF-968325C7C047Q38386911-AD69BEBB-305D-4501-A827-39990765728EQ38621427-B23920E9-D6D3-4BE3-9C12-28768CB22433Q38925668-0F01759B-A3A6-4AC0-BA89-80F03DAE32BEQ39272441-C4FE5A93-8588-47A6-B534-2D57A564870CQ39451885-788347CB-E4B1-4B84-9C97-19C519708898Q40558826-424F1C37-71EB-4AAD-962B-F80A1A54FC01Q41252057-248A792F-9745-48BF-9410-4C6DB89E8B97Q42002175-D264D908-4407-456D-8529-486A77F6F7ACQ46024767-C9343016-DBB3-449A-B316-3CEC4988FC85Q51790901-E45A1261-01C3-43C0-A1D0-7B28834F7691Q54157122-566A38DB-E08C-4600-9CAC-63429A1DB801Q54208548-59865750-C912-470A-B2D5-C107BC8B8CB7Q56768358-68E4FFB5-BCD8-4A4A-ADDB-F17C9697E478
P2860
A purified Bacillus thuringiensis crystal protein with therapeutic activity against the hookworm parasite Ancylostoma ceylanicum.
description
2006 nî lūn-bûn
@nan
2006 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
A purified Bacillus thuringien ...... rasite Ancylostoma ceylanicum.
@ast
A purified Bacillus thuringien ...... rasite Ancylostoma ceylanicum.
@en
type
label
A purified Bacillus thuringien ...... rasite Ancylostoma ceylanicum.
@ast
A purified Bacillus thuringien ...... rasite Ancylostoma ceylanicum.
@en
prefLabel
A purified Bacillus thuringien ...... rasite Ancylostoma ceylanicum.
@ast
A purified Bacillus thuringien ...... rasite Ancylostoma ceylanicum.
@en
P2093
P2860
P356
P1476
A purified Bacillus thuringien ...... rasite Ancylostoma ceylanicum.
@en
P2093
Brad D Barrows
Joel S Griffitts
Larry J Bischof
Lisa M Harrison
Michael Cappello
Raffi V Aroian
Richard D Bungiro
P2860
P304
15154-15159
P356
10.1073/PNAS.0607002103
P407
P577
2006-09-27T00:00:00Z